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Endovascular stenting versus open surgery for
thoracic aortic disease: Systematic review and
meta-analysis of perioperative results
Stewart R. Walsh, MRCSEd, Tjun Y. Tang, MRCS, Umar Sadat, MB, BS, Jag Naik, FRCS,
Michael E. Gaunt, MD, FRCS, Jonathan, R. Boyle, FRCS, Paul D. Hayes, FRCS, and
Kevin Varty, FRCS, Cambridge, United Kingdom
Background: Endovascular stenting has emerged as an alternative to open repair in patients requiring surgery for thoracic
aortic pathology. A number of comparative series have been published but, to date, there has been no meta-analysis
comparing outcomes following stenting as opposed to open surgery.
Methods: Electronic abstract databases and conference proceedings were searched to identify relevant series. Pooled odds ratios
were calculated using random effects models for perioperative mortality, neurological injury, and major reintervention.
Results: The search identified 17 eligible series, totaling 1109 patients (538 stenting). Stenting was associated with a
significant reduction in mortality (pooled odds ratio 0.36; 95% CI 0.228-0.578; P < .0001) and major neurological
injury (pooled odds ratio 0.39; 95% CI 0.25-0.62; P  .0001). There was no difference in the major reintervention rate
(pooled odds ratio 0.91; 95% CI 0.610-1.619). There was a reduction in hospital and critical care stay although there was
evidence of heterogeneity and bias with respect to these outcomes. Subgroup analyses suggested that endovascular repair
reduced mortality (pooled odds ratio 0.25; 95% CI 0.09-0.66) and neurological morbidity (pooled odds ratio 0.28; 95%
CI 0.13-0.61) in stable patients undergoing repair of thoracic aortic aneurysms. There was no effect on mortality in
patients with thoracic aortic trauma but neurological injury was reduced (pooled odds ratio 0.17; 95% CI 0.03-1.03).
Endovascular repair did not confer any apparent benefit over open surgery in patients with thoracic aortic rupture.
Conclusion: Endovascular thoracic aortic repair reduces perioperative mortality and neurological morbidity in patients
with descending thoracic aortic aneurysms. There may be less benefit in other thoracic aortic conditions. ( J Vasc Surg
2008;47:1094-8.)The rate at which thoracic aortic pathology is discov-
ered is increasing. In Sweden, the detection of thoracic
aortic disease (aneurysm or dissection) rose by 52% in men
between 1987 and 2002, though the anatomical distribu-
tion (ascending aorta, aortic arch, or descending aorta) was
not examined. It now affects 16.3 per 100,000 Swedish
men and 9.1 per 100,000 women.1 Data from the United
States also suggest that thoracic aortic disease (TAD) is
becoming more common.2 The rise is probably artifactual,
resulting from improvements in diagnosis.3 Nevertheless,
cardiothoracic and vascular specialists are increasingly
called upon to manage patients with TAD. For many years,
open surgical repair or conservative medical treatment were
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1094the only available treatment modalities for TAD. Reported
perioperative mortality following open surgery for de-
scending thoracic aortic aneurysm ranges from 2.7%4 to
8%,5 increasing to 29% in traumatic descending thoracic
aortic rupture.6 More recently, endovascular stent-grafting
has emerged as a therapeutic option for thoracic aortic
aneurysms, dissections, trauma, and other pathology.7,8 A
meta-analysis of stent-grafting for aortic dissections sug-
gested that technical success is achieved in about 98% of
patients, although major complications occurred in 14% to
18% of patients and there may be a 5% perioperative mor-
tality.9 Endovascular management of aortic trauma is asso-
ciated with a 1.5% perioperative mortality and a 14% mor-
bidity rate.10 Open surgery may achieve similar
perioperative mortality results.11 Neither meta-analysis
published to date included a comparison with the results of
open surgery.9,10 We undertook a systematic review and
meta-analysis in order to compare the results of open
surgery with endovascular repair for TAD.
METHODS
The Pubmed and Embase databases were searched
from January 1991 to March 2007. Combinations of the
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racic”, “surgery”, “open”, “aortic”, and “aorta” were used.
There were no limits set on the searches. We aimed to
identify series that reported the results of endovascular
treatment of thoracic aortic pathology compared with open
surgery. Review articles, editorials, and case reports were
not included. Conference proceedings from major cardio-
thoracic, vascular, and endovascular meetings (European
Association of Cardiothoracic Surgery, Society of Vascular
Surgery, European Society of Vascular Surgery, American
Association of Thoracic Surgery, Vascular Society of Great
Britain and Ireland, the International Congress on Endo-
vascular Interventions, and the Western Thoracic Surgical
Association) from 2000 to 2006 were hand searched to
identify additional series. Abstracts identified by the search
were scrutinized to determine if the study was eligible for
inclusion. The reference lists of eligible series were exam-
ined to identify any further relevant articles.
The quality of eligible studies was assessed by the
Downs and Black score.12 Papers are assessed against 27
criteria, which evaluate reporting, external validity, bias,
confounding, and power. Possible scores range from a
minimum of 0 to a maximum score of 31. Data were
extracted from the papers or abstracts into a computerized
spreadsheet for analysis. The primary outcomes of interest
were 30-day mortality, reintervention rates, and major neu-
rological injury (spinal cord injury or cerebrovascular acci-
dent). Secondary outcomes were critical care unit stay and
Table I. Characteristics and quality scores of eligible stud
Series Year Prospective Conditio
Bavaria15 2007 Partial; some
historical open
controls
Descending T
McPhee22 2007 No Blunt thoraci
Andrassy14 2006 No Acute and ch
injury of de
thoracic ao
Buz17 2006 No Acute trauma
rupture
Reed26 2006 No Blunt thoraci
Stone28 2006 No Aneurysms, tr
dissection
Aasland12 2005 No Descending T
dissection
Glade20 2005 No Descending T
Kuhne21 2005 No Acute trauma
Rousseau27 2005 No Acute trauma
Amabile13 2004 No Acute trauma
Brandt16 2004 No Descending T
rupture, dis
Morishita23 2004 No Thoracic aort
Doss18 2003 No Thoracic aort
Najibi24 2002 No Descending T
Nienaber25 1999 Yes Thoracic aort
Ehrlich19 1998 No Thoracic aort
dissectionhospital stay. Pooled odds ratios were calculated for theprimary outcomes using a random effects model as per Der
Simonian and Laird.13 Effect size estimates were calculated
for the secondary outcomes. Statistical heterogeneity was
assessed by Cochran Q test, a null hypothesis test in which
a P value less than .05 indicates significant heterogeneity.
Publication bias was assessed by visual inspection of funnel
plots and by the Egger test. The 5% level was considered
significant. The statistical analysis was performed using
Statsdirect 2.5.7 (Statsdirect Ltd, Altrincham, UK).
RESULTS
The initial screen of electronic databases and abstracts
books identified 2751 citations. Of these, 257 contained
data on outcome following stenting. A comparison be-
tween open and endovascular thoracic aortic repair was
provided by 17 studies.12-28 Data from these series were
abstracted for analysis.
Study characteristics and quality assessment. The
characteristics of the eligible studies are summarized in
Table I. Only a single study was conducted prospectively.14
The majority included patients undergoing elective and
emergency procedures. The Downs and Black scores
ranged from 9 to 20, indicating that the studies were of
only moderate quality. The outcomes reported by each
series are summarized in Table II, online only.
Perioperative mortality. Information regarding peri-
operative mortality was provided by 17 studies, totaling
1109 patients (538 endovascular; 571 open surgery).12-28
luded
Emergency
procedures
included Open Stent
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ic aneThere was no evidence of heterogeneity (Cochran Q 10.57;
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deaths in the stenting group (5.57%) and 94 deaths in the
open arm (16.5%). Endovascular stenting was associated
with a significant reduction in perioperative mortality
(pooled odds ratio 0.36; 95% CI 0.228-0.578; P .0001)
(Fig 1, online only).
Major neurological injury. The incidence of major
perioperative neurological morbidity was reported by 16
series.12-20,22-28 In three series, no events were observed in
either arm.15-17 The remaining 13 series (958 patients)
were used for this meta-analysis.12,14-16,18-20,22-25,27,28
Major neurological complications occurred in 26 stent
patients (5.4%) and 67 open patients (14%). Once again,
there was no evidence of significant heterogeneity (Coch-
ran Q 10.08; P .61) or bias (Egger 0.26; P .61). The
risk of major neurological injury was significantly reduced by
endovascular stenting (pooled odds ratio 0.39; 95% CI 0.25-
0.62; P .0001) (Fig 2, online only). We repeated the analysis
for the perioperative stroke and paraplegia subgroups. The
risk of stroke was not affected by endovascular stenting
(pooled odds ratio 0.77; 95% CI 0.38-1.59; P .48). Stent-
ing was associated with a reduced risk of paraplegia (pooled
odds ratio 0.33; 95% CI 0.18-0.63; P .0007).
Major reintervention. Major reinterventions (fur-
ther invasive procedure required to manage complica-
tions) were reported by nine series, totaling 769 pa-
tients.13,15-18,20,23,24,28 There was no evidence of
heterogeneity (Cochran Q 6.61; P .58) or bias (Egger
0.43; P .50). Major reinterventions were required in
29 stent patients (7%) and 30 open patients (8.4%).
Re-interventions in the stent group included 13 patients
requiring repeat endovascular repairs, five needing revi-
sions using open surgery and six patients who underwent
peripheral vascular surgical revascularizations. In the
open group, 14 patients required reexploration for
bleeding, five needed additional aortic procedures, and
10 patients underwent various procedures including
drainage of a hemopericardium and false aneurysm re-
pair. Endovascular stenting had no impact on the major
reintervention rate (pooled odds ratio 0.91; 95% CI
0.610-1.619) (Fig 3, online only).
Length of hospital and ITU stay. Seven series (468
patients) provided data regarding length of hospital and
ITU stay.14,18-23 The pooled effect size estimate suggested
that the length of ITU stay post-operatively was reduced by
1.26 days in the stenting group (95% CI1.77 to0.76;
P .0001). Similarly, the length of hospital stay was re-
duced in the stenting arm (pooled effect size 1.00 days;
95% CI 1.58 to 0.45 days; P  .0004). However, the
funnel plots for both hospital stay (Fig 4, online only) and
ITU stay (Fig 5, online only) displayed asymmetry. The
Cochran Q test for hospital stay was significant (Cochrans
Q 31.21; P  .0001), indicating significant heterogeneity
between the studies. Thus, the pooled effect size estimates
are based on biased, heterogenous data and should be
treated with considerable caution.
Emergency vs elective surgery. Of the 17 studies, 14
included a mix of both elective and emergency procedures.Emergency surgery for thoracic aortic pathology is associ-
ated with a considerable mortality24, 25. In view of this, we
repeated the meta-analysis using the three studies that were
restricted to elective cases only (64 stenting patients; 123
open surgery) 14, 21, 26. The apparent benefits of stenting
persisted. Peri-operative mortality was lower in the stenting
arm (4.8% versus 20.3%; pooled odds ratio 0.23; 95% CI
0.09-0.59; P .0016). There was also a persistent benefit
in terms of major neurological complications (9.4% versus
14.6%; pooled odds ratio 0.27; 95% CI 0.13-0.58; P
.0012). There was no benefit with respect to major
reinterventions (12.5% versus 12.1%; pooled odds ratio
1.05; 95% CI 0.17-6.66; P .96).
Stenting vs open surgery for descending thoracic
aortic aneurysms. Different aortic pathologies may also
affect outcome. Consequently, we repeated the meta-anal-
yses for specific aortic conditions. Three studies included
patients with descending thoracic aortic aneurysms
only19,23,26. Unstable patients were excluded. Endovascular
repair was performed in 201 patients and compared to 157
patients undergoing open repair. Mortality was significantly
lower in the endovascular group (pooled odds ratio 0.25; 95%
CI 0.09-0.66; P .005). Major neurological injury was also
reduced (pooled odds ratio 0.28; 95% CI .13-.61; P.0013)
while major reintervention rates were unaffected (pooled odds
ratio 1.04; 95% CI 0.29-3.66; P.95).
Stenting vs open surgery for thoracic aortic trauma.
Seven series were restricted to patients with thoracic aortic
trauma.15-18, 22,27,28 Endovascular repair in 119 patients
was compared with open repair in 155 patients. There was
no significant reduction in mortality (pooled odds ratio
0.47; 95% CI 0.19-1.14; P .09) or major reinterventions
(pooled odds ratio 1.17; 95% CI 0.11- 11.84; P .89).
Neurological injury was lower in the endovascular group
(pooled odds ratio 0.17; 95% CI 0.03-1.03; P .05).
Stenting versus open surgery for thoracic aortic
rupture. Two series were restricted to patients with acute
thoracic aortic rupture.29,30 Endovascular repair in 44 pa-
tients was compared with open repair in 39. There was no
significant difference in mortality (pooled odds ratio 0.58;
95% CI 0.06-6.02; P  .65), major neurological injury
(pooled odds ratio 0.26; 95% CI 0.03-2.59; P  .25), or
major reinterventions (pooled odds ratio 0.84; 95% CI
0.02-29.39; P .92).
Stenting versus open surgery for thoracic aortic
dissection. No meta-analysis was possible for this sub-
group as only a single study was restricted to patients with
aortic dissection.14
DISCUSSION
New and emerging treatment strategies ideally require
robust evaluation before they can be adopted as routine
clinical practice. Usually, this requires meta-analysis of a
sufficient body of randomized trials to determine the effi-
cacy of the new strategy beyond reasonable doubt. Occa-
sionally, however, a new treatment emerges which has such
a large perceived benefit over the conventional alternative
that clinicians believe there is insufficient equipoise to
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represent such an advance. Despite advances in surgical and
critical care technology, open thoracic aortic surgery is still
associated with a very significant morbidity and mortality,
particularly in the emergency setting.31 Stenting avoids the
deleterious effects of a thoracotomy, thoracic aortic cross
clamping, and major blood loss. The apparent advantages
of stenting are such that a randomized trial may never be
considered ethical.
Two previous meta-analyses of thoracic stenting have
not compared the results of stenting with the open alterna-
tive, instead merely providing pooled outcome data for
stenting alone.9,10 To the best of our knowledge, our
meta-analysis is the only one to date that compares out-
comes between endovascular and open surgery. The anal-
ysis demonstrated a significant benefit for stenting with
respect to perioperative mortality and major neurological
injury. There was no difference in major reintervention
rates. This contrasts with findings from randomized trials in
endovascular abdominal aortic aneurysm repair, which sug-
gest that postoperative complications requiring reinterven-
tion are significantly more common following endovascular
repair.32 However, the length of follow-up of the endovas-
cular patients varied considerably between the series in-
cluded in the meta-analysis, ranging from 12 months23,29
to 4 years.33 Several years of post-procedure surveillance
would be necessary to accurately assess the reintervention
rate in the stenting arm. We would caution against using
our result to suggest that thoracic stenting has a reinterven-
tion rate comparable with open surgery.
The studies included in the meta-analysis were assessed
for quality using the structured assessment tool derived by
Downs and Black.12 The maximum score obtained was 20,
out of a possible 31. Thus, the studies included were of
moderate quality, at best. The majority were retrospective.
The length of follow-up and definitions of complications
were variable, introducing potential bias into the meta-
analysis. A number of series used historical open con-
trols18,19,28 even though the results of open surgery have
improved in the last two decades.11 Use of adjuncts such as
spinal drainage was variable.18,19,22,26,33 Moreover, the
methods by which open cases were selected for use as
controls was not always clear.18,19 The use of selected,
nonconsecutive cases as controls may have introduced an-
other potential bias into the meta-analysis.
The cohort used for the meta-analysis was extremely
heterogenous, containing a mixture of pathologies as well
as both emergency and elective patients. Emergency tho-
racic aortic surgery is associated with a greater risk of
perioperative morbidity and mortality compared with open
surgery. Similarly, patients with thoracic aortic trauma of-
ten have concomitant injuries that may lead to a poor
outcome, regardless of the type of thoracic aortic interven-
tion used. We attempted to account for these confounders
by subgroup analyses, although this led to some loss of
power as the numbers included in the subgroups were
small. Restricting the analysis to the three series containing
only elective patients showed a persistent benefit in terms ofmortality and perioperative neurological injury, although
the patients underwent a mix of descending thoracic aneu-
rysm repair21,26 and repair of type B dissections.14 We also
performed subgroup analyses restricted by aortic pathol-
ogy. These analyses suggest that stenting confers most
benefit in patients with descending thoracic aortic aneu-
rysms, reducing both mortality and neurological complica-
tions. There was no apparent benefit in patients with acute
thoracic aortic rupture, although the number of patients
available (44 stenting vs 39 open) provides only limited
power. In trauma patients, neurological morbidity was
reduced but mortality was unaffected. This may reflect the
impact of other injuries on outcome in trauma patients.
Stenting appears to reduce the length of hospital and
critical care unit stay.
The three elective series in our meta-analysis reported
mean hospital stays of 6 to 10 days following stenting
compared with 13 to 40 days following open repair.14,21,26
Similarly, ITU stay was reduced, averaging 1.5 to 11 days
following a stent compared with between 4 and 14 days
following open surgery.14,21,26 However, there was evi-
dence of both heterogeneity and bias. The reasons for this
are unclear, although variation in critical care bed availabil-
ity and practice in the United States, United Kingdom, and
Europe may be partly responsible for the apparent hetero-
geneity between series.
Our systematic review suggests that the endovascular
approach improves perioperative mortality and neurologi-
cal injury in stable patients requiring intervention for tho-
racic aortic aneurysms. There was also some benefit with
respect to neurological complications in patients with tho-
racic aortic trauma. There was no apparent benefit in pa-
tients with nontraumatic rupture. The meta-analysis only
considered perioperative outcomes. The effects on hospital
resource utilization and long-term outcome are unknown
and there has been no comprehensive cost-effectiveness
analysis. This is an important consideration, particularly as
abdominal aortic aneurysm repair is significantly more ex-
pensive than open.32 Moreover, some series used historical
open controls,19 whose complication rates may not accu-
rately reflect contemporary practice. About a quarter of
patients with thoracic aortic aneurysms are anatomically
unsuitable for endovascular repair.34 Consequently, there
is an inherent bias in any comparison of endovascular
treatment with open surgery, as not all patients undergoing
open surgery will be suitable for stenting. The two modal-
ities should be viewed as complementary, not competitive.
It must be remembered that these conclusions are
based upon studies of only moderate quality. There was
considerable variation in the outcomes reported. At a min-
imum, future reports should provide 30-day mortality
rates, cerebrovascular accident, paraplegia, and major rein-
tervention rates for both endovascular and open surgical
patients. Comparisons with historical open controls should
be avoided, instead using only consecutive, contemporane-
ous control patients. These measures would provide higher
quality studies, allowing more robust conclusions to be
JOURNAL OF VASCULAR SURGERY
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Series Total Morta
Bavaria15 Open 94 11
Stent 140 3
McPhee22 Open 5 1
Stent 8 2
Andrassy14 Open 22 3
Stent 24 2
Buz17 Open 35 8
Stent 31 2
Reed26 Open 11 1
Stent 13 3
Stone28 Open 93 14
Stent 105 8
Aasland12 Open 35 5
Stent 25 1
Glade20 Open 53 6
Stent 42 2
Kuhne21 Open 36 6
Stent 5 0
Rousseau27 Open 35 6
Stent 29 0
Amabile13 Open 11 1
Stent 9 0
Brandt16 Open 22 6
Stent 22 1
Morishita23 Open 11 1
Stent 18 3
Doss18 Open 28 5
Stent 26 1
Najibi24 Open 10 1
Stent 19 1
Nienaber25 Open 12 1
Stent 12 0
Ehrlich19 Open 58 18
Stent 10 1series eligible for inclusion in the meta-analysis
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stenting on perioperative mortality following treatment of thoracic
aortic pathology (Observed events 30/538 endovascular; 94/571
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Fig 4. (online only). Funnel plot for length of hospital stay.Fig 2. (online only). Forest plot comparing major neurological
injury between endovascular and open repair (Observed events
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